Skip to main content
ROHTO PHARMACEUTICAL CO.,LTD. logo

ROHTO PHARMACEUTICAL CO.,LTD. — Investor Relations & Filings

Ticker · 4527 ISIN · JP3982400008 LEI · 353800Q1CW5OS81OUM12 T Manufacturing
Open in API
Filings indexed 74 across all filing types
Latest filing 2019-02-14 Interim / Quarterly Rep…
Country JP Japan
Listing T 4527

About ROHTO PHARMACEUTICAL CO.,LTD.

https://www.rohto.co.jp/global/

Rohto Pharmaceutical Co., Ltd. is a multinational company that manufactures and markets a wide range of health and beauty care products. The company's core business areas are over-the-counter (OTC) pharmaceuticals and skincare. It is a recognized leader in the eye care market, particularly known for its extensive line of eye drops. The product portfolio also includes skincare, oral medications, and functional foods. Rohto Pharmaceutical focuses on research and development to create innovative products and services that support the physical and mental well-being of consumers worldwide, aiming to contribute to the future potential of society through health.

Recent filings

Filing Released Lang Actions
四半期報告書－第83期第3四半期(2018/10/01－2018/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, management analysis, and auditor review information for the third quarter of the 83rd fiscal period. It is a comprehensive financial report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-02-14 Japanese
四半期報告書－第83期第2四半期(2018/07/01－2018/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau. It contains detailed financial statements, management analysis (MDA), and corporate information for the second quarter of the 83rd fiscal period (April 1, 2018, to September 30, 2018). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. H1 2019
2018-11-14 Japanese
四半期報告書－第83期第1四半期(2018/04/01－2018/06/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, as indicated by the header and the regulatory reference (Financial Instruments and Exchange Act). It contains detailed financial statements, including the consolidated balance sheet, for the first quarter of the 83rd fiscal period (April 1, 2018, to June 30, 2018). It includes substantive financial data and analysis, fitting the definition of an Interim/Quarterly Report (IR). Q1 2019
2018-08-10 Japanese
有価証券報告書－第82期(平成29年4月1日－平成30年3月31日)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuuka Shouken Houkokusho' (Securities Report), which is the Japanese equivalent of a 10-K annual report. It contains the header information for the 82nd fiscal year (April 1, 2017 to March 31, 2018) and is filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. The document structure and metadata confirm it is the comprehensive annual financial filing for Rohto Pharmaceutical Co., Ltd. FY 2018
2018-06-25 Japanese
四半期報告書－第82期第3四半期(2017/10/01－2017/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) for Rohto Pharmaceutical Co., Ltd., covering the third quarter of the 82nd fiscal period. It includes detailed financial statements (balance sheets, etc.), management analysis of financial results, and regulatory disclosures required under the Financial Instruments and Exchange Act of Japan. As it contains comprehensive financial data for an interim period, it is classified as an Interim/Quarterly Report. 9M 2018
2018-02-13 Japanese
四半期報告書－第82期第2四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by Rohto Pharmaceutical Co., Ltd. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis of financial conditions, and results of operations for the second quarter of the 82nd fiscal year. It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report (IR). Q2 2017
2017-11-13 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.